{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "JPY", "marketState": "CLOSED", "regularMarketChangePercent": 0.0, "regularMarketPrice": 828.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -93.86, "epsForward": 112.7, "sharesOutstanding": 16336200, "bookValue": 256.136, "fiftyDayAverage": 556.76, "fiftyDayAverageChange": 271.24, "fiftyDayAverageChangePercent": 0.48717576, "twoHundredDayAverage": 706.875, "twoHundredDayAverageChange": 121.125, "twoHundredDayAverageChangePercent": 0.17135279, "marketCap": 14278859776, "forwardPE": 7.346939, "priceToBook": 3.232658, "sourceInterval": 15, "exchangeDataDelayedBy": 20, "averageAnalystRating": "1.0 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "exchange": "JPX", "shortName": "CARNA BIOSCIENCES INC", "longName": "Carna Biosciences, Inc.", "messageBoardId": "finmb_22771969", "exchangeTimezoneName": "Asia/Tokyo", "exchangeTimezoneShortName": "JST", "gmtOffSetMilliseconds": 32400000, "market": "jp_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1206403200000, "priceHint": 2, "regularMarketChange": 0.0, "regularMarketTime": 1683872101, "regularMarketDayHigh": 857.0, "regularMarketDayRange": "780.0 - 857.0", "regularMarketDayLow": 780.0, "regularMarketVolume": 1826700, "regularMarketPreviousClose": 828.0, "bid": 827.0, "ask": 833.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Tokyo", "financialCurrency": "JPY", "regularMarketOpen": 801.0, "averageDailyVolume3Month": 671155, "averageDailyVolume10Day": 1640870, "fiftyTwoWeekLowChange": 381.0, "fiftyTwoWeekLowChangePercent": 0.852349, "fiftyTwoWeekRange": "447.0 - 984.0", "fiftyTwoWeekHighChange": -156.0, "fiftyTwoWeekHighChangePercent": -0.15853658, "fiftyTwoWeekLow": 447.0, "fiftyTwoWeekHigh": 984.0, "earningsTimestamp": 1683700200, "earningsTimestampStart": 1691060340, "earningsTimestampEnd": 1691409600, "trailingAnnualDividendRate": 0.0, "symbol": "4572.T"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "BMA, 1-5-5 Minatojima-Minamimachi", "address2": "3rd Floor Chuo-ku", "city": "Kobe", "zip": "650-0047", "country": "Japan", "phone": "81 78 302 7039", "fax": "81 78 302 6665", "website": "https://www.carnabio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Carna Biosciences, Inc., a clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan. Its products include kinase proteins, substrates, kinase protein assay kits, and stable cell lines, as well as biotinylated kinases. The company also offers profiling, NanoBRET TE intracellular kinase cell-based assay, protein detection and interaction, live-cell kinase assay, and tyrosine kinase cell-based assay services. It also focuses on developing products for the treatment of various diseases, such as AS-0141, an orally bioavailable small molecule inhibitor of CDC7 kinase that is in preclinical trials to treat cancer; AS-0871, a small molecule drug for inflammatory and immune disorders, which is in Phase 1 clinical trials; and AS-1763, an orally bioavailable and non-covalent inhibitor for the treatment of chronic lymphocytic leukemia and other B cell malignancies that is in preclinical trials. The company has collaborations with Johnson & Johnson, Sierra Oncology, Sumitomo Dainippon Pharma, Gilead Sciences, and BioNova Pharmaceuticals. Carna Biosciences, Inc. was incorporated in 2003 and is based in Kobe, Japan.", "fullTimeEmployees": 65, "companyOfficers": [{"maxAge": 1, "name": "Dr. Kohichiro  Yoshino Ph.D.", "age": 73, "title": "CEO, Pres & Representative Director", "yearBorn": 1949, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Emi  Yamamoto", "title": "CFO, Director and Pres of CarnaBio USA, Inc", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Masaaki  Sawa Ph.D.", "age": 52, "title": "Chief Scientific Officer & Director", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Norio  Aikawa", "age": 74, "title": "Head of Drug Discovery & Support Bus., Head of IP & Legal Department and Director", "yearBorn": 1948, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Akinori  Arimura Ph.D.", "age": 59, "title": "Chief Devel. Officer & Director", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}